These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 24922356)

  • 1. Angiogenesis and proliferation markers in adjacent cirrhotic tissue could predict hepatocellular carcinoma outcome after liver transplantation.
    Campillo A; Solanas E; Morandeira MJ; Castiella T; Lorente S; Garcia-Gil FA; Piazuelo E; de Martino A; Serrano MT
    Eur J Gastroenterol Hepatol; 2014 Aug; 26(8):871-9. PubMed ID: 24922356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver.
    El-Assal ON; Yamanoi A; Soda Y; Yamaguchi M; Igarashi M; Yamamoto A; Nabika T; Nagasue N
    Hepatology; 1998 Jun; 27(6):1554-62. PubMed ID: 9620326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin-2 and hypoxia-induced factor-1 alpha.
    Wada H; Nagano H; Yamamoto H; Yang Y; Kondo M; Ota H; Nakamura M; Yoshioka S; Kato H; Damdinsuren B; Tang D; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Sakon M; Dono K; Wakasa K; Monden M
    Liver Int; 2006 May; 26(4):414-23. PubMed ID: 16629644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma.
    Yang XR; Xu Y; Yu B; Zhou J; Qiu SJ; Shi GM; Zhang BH; Wu WZ; Shi YH; Wu B; Yang GH; Ji Y; Fan J
    Gut; 2010 Jul; 59(7):953-62. PubMed ID: 20442200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular mechanism underlying angiogenesis in hepatocellular carcinoma: the imbalance activation of signaling pathways.
    Zhao ZC; Zheng SS; Wan YL; Jia CK; Xie HY
    Hepatobiliary Pancreat Dis Int; 2003 Nov; 2(4):529-36. PubMed ID: 14627514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The angiogenic makeup of human hepatocellular carcinoma does not favor vascular endothelial growth factor/angiopoietin-driven sprouting neovascularization.
    Zeng W; Gouw AS; van den Heuvel MC; Zwiers PJ; Zondervan PE; Poppema S; Zhang N; Platteel I; de Jong KP; Molema G
    Hepatology; 2008 Nov; 48(5):1517-27. PubMed ID: 18924243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of p53, Bcl-2, VEGF, Ki67 and PCNA and prognostic significance in hepatocellular carcinoma.
    Stroescu C; Dragnea A; Ivanov B; Pechianu C; Herlea V; Sgarbura O; Popescu A; Popescu I
    J Gastrointestin Liver Dis; 2008 Dec; 17(4):411-7. PubMed ID: 19104702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial serum VEGF-A, angiopoietin-2, and endostatin measurements in cirrhotic patients with hepatocellular carcinoma treated by transcatheter arterial chemoembolization.
    Hsieh MY; Lin ZY; Chuang WL
    Kaohsiung J Med Sci; 2011 Aug; 27(8):314-22. PubMed ID: 21802642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic significance of vasohibin 1-associated angiogenesis in patients with hepatocellular carcinoma.
    Murakami K; Kasajima A; Kawagishi N; Sekiguchi S; Fujishima F; Watanabe M; Sato Y; Ohuchi N; Sasano H
    Hum Pathol; 2014 Mar; 45(3):589-97. PubMed ID: 24444468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular density and VEGF expression in hepatic lesions.
    Brodsky SV; Mendelev N; Melamed M; Ramaswamy G
    J Gastrointestin Liver Dis; 2007 Dec; 16(4):373-7. PubMed ID: 18193117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tumor microvascular density detected by anti-CD105 and anti-CD34 in hepatocellular carcinoma patients and its predictive value of tumor recurrence after liver transplantation].
    Wang Y; Zhang XH; Guo P; Yan LN; He D
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 41(5):818-21. PubMed ID: 21302449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue factor expression correlates with tumor angiogenesis and invasiveness in human hepatocellular carcinoma.
    Poon RT; Lau CP; Ho JW; Yu WC; Fan ST; Wong J
    Clin Cancer Res; 2003 Nov; 9(14):5339-45. PubMed ID: 14614019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?
    Adam R; Azoulay D; Castaing D; Eshkenazy R; Pascal G; Hashizume K; Samuel D; Bismuth H
    Ann Surg; 2003 Oct; 238(4):508-18; discussion 518-9. PubMed ID: 14530722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered p-STAT3 (tyr705) expression is associated with histological grading and intratumour microvessel density in hepatocellular carcinoma.
    Yang SF; Wang SN; Wu CF; Yeh YT; Chai CY; Chunag SC; Sheen MC; Lee KT
    J Clin Pathol; 2007 Jun; 60(6):642-8. PubMed ID: 16901975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinically relevant biomarkers to select patients for targeted inhibitor therapy after resection of hepatocellular carcinoma.
    Patel SH; Kneuertz PJ; Delgado M; Kooby DA; Staley CA; El-Rayes BF; Kauh JS; Sarmiento JM; Hanish S; Cohen C; Farris AB; Maithel SK
    Ann Surg Oncol; 2011 Nov; 18(12):3384-90. PubMed ID: 21590454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microscopic vascular invasion detected by anti-CD34 immunohistochemistry as a predictor of recurrence of hepatocellular carcinoma after liver transplantation.
    Salizzoni M; Romagnoli R; Lupo F; David E; Mirabella S; Cerutti E; Ottobrelli A
    Transplantation; 2003 Sep; 76(5):844-8. PubMed ID: 14501865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of metallothionein-1 and metallothionein-2 as a prognostic marker in hepatocellular carcinoma.
    Park Y; Yu E
    J Gastroenterol Hepatol; 2013 Sep; 28(9):1565-72. PubMed ID: 23662831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor receptor 2 expression in non-tumorous cirrhotic liver is higher when hepatoma is beyond Milan criteria.
    Aucejo F; Kim R; Zein N; Quintini C; Uso TD; Lopez R; Eghtesad B; Fung J; Miller C; Yerian L
    Liver Transpl; 2009 Feb; 15(2):169-76. PubMed ID: 19177438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of AGGF1 is correlated with angiogenesis and poor prognosis of hepatocellular carcinoma.
    Wang W; Li GY; Zhu JY; Huang DB; Zhou HC; Zhong W; Ji CS
    Med Oncol; 2015 Apr; 32(4):131. PubMed ID: 25796501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlates with angiogenesis.
    Matsubara T; Kanto T; Kuroda S; Yoshio S; Higashitani K; Kakita N; Miyazaki M; Sakakibara M; Hiramatsu N; Kasahara A; Tomimaru Y; Tomokuni A; Nagano H; Hayashi N; Takehara T
    Hepatology; 2013 Apr; 57(4):1416-25. PubMed ID: 22815256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.